An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia

Journal of Alzheimer's Disease

Volumn 53, Issue 2, 2016, Pages 393-402

  Li, Wei ^a   Huang, Edgar ^b  

^a INDIANA UNIVERSITY   (United States)

^b Indiana University   (United States)

Author keywords

Alzheimer's disease; Mild cognitive impairment; Type 2 diabetes mellitus; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; BIOLOGICAL MARKER; CHOLESTEROL; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN ATROPHY; CHOLESTEROL BLOOD LEVEL; DEMENTIA; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; BIBLIOGRAPHIC DATABASE; BRAIN; COGNITIVE DEFECT; METABOLISM; PATHOLOGY; STATISTICS AND NUMERICAL DATA;

AMYLOID BETA-PEPTIDES; BRAIN; COGNITIVE DYSFUNCTION; DATABASES, BIBLIOGRAPHIC; DEMENTIA; DIABETES MELLITUS, TYPE 2; HUMANS; RISK FACTORS; TAU PROTEINS;

EID: 84979221681     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160114     Document Type: Review

References (98)

1. Rivillas-Acevedo L, Sánchez-López C, Amero C, Quintanar L (2015) Structural basis for the inhibition of truncated islet amyloid polypeptide aggregation by Cu(II): Insights into the bioinorganic chemistry of type II diabetes. Inorg Chem 54, 3788-3796.
2. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM (1996) Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 39, 1392-1397.
3. Cheng PY, Sy HN, Wu SL, Wang WF, Chen YY (2012) Newly diagnosed type 2 diabetes and risk of dementia: A population-based 7-year follow-up study in Taiwan. J Diabetes Complications 26, 382-387.
4. Smolina K,Wotton CJ, Goldacre MJ (2015) Risk of dementia in patients hospitalised with type 1 and type 2 diabetes in England, 1998-2011: A retrospective national record linkage cohort study. Diabetologia 58, 942-950.
5. Cheng C, Lin CH, Tsai YW, Tsai CJ, Chou PH, Lan TH (2014) Type 2 diabetes and antidiabetic medications in relation to dementia diagnosis. J Gerontol A Biol Sci Med Sci 69, 1299-1305.
6. Fei M, Yan Ping Z, Ru Juan M, Ning Ning L, Lin G (2013) Risk factors for dementia with type 2 diabetes mellitus among elderly people in China. Age Ageing 42, 398-400.
7. Lin CH, SheuWH(2013) Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study. J Intern Med 273, 102-110.
8. West RK, Ravona-Springer R, Heymann A, Schmeidler J, Leroith D, Koifman K, Guerrero-Berroa E, Preiss R, Hoffman H, Silverman JM, Beeri MS (2015) Shorter adult height is associated with poorer cognitive performance in elderly men with type II diabetes. J Alzheimers Dis 44, 927-935.
9. Mayeda ER, Haan MN, Neuhaus J, Yaffe K, Knopman DS, Sharrett AR, Griswold ME, Mosley TH (2014) Type 2 diabetes and cognitive decline over 14 years in middle-aged African Americans and whites: The ARIC BrainMRIStudy. Neuroepidemiology 43, 220-227.
10. Percy M, Somerville MJ, Hicks M, Garcia A, Colelli T, Wright E, Kitaygorodsky J, Jiang A, Ho V, Parpia A,Wong MK (2014) Risk factors for development of dementia in a unique six-year cohort study. I. An exploratory, pilot study of involvement of the E4 allele of apolipoprotein E, mutations of the hemochromatosis-HFE gene, type 2 diabetes, and stroke. J Alzheimers Dis 38, 907-922.
11. van Eersel ME, Joosten H, Gansevoort RT, Dullaart RP, Slaets JP, Izaks GJ (2013) The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older. PLoS One 8, e82991.
12. Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, Launer LJ (2008) Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: The Cardiovascular Health Study Cognition Study. Arch Neurol 65, 89-93.
13. Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, JagustWJ(2003) Prevalence of dementia in older latinos: The influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc 51, 169-177.
14. Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, Kappelle LJ, Biessels GJ (2006) Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55, 1106-1113.
15. Zhang J, Wang Y, Wang J, Zhou X, Shu N, Wang Y, Zhang Z (2014) White matter integrity disruptions associated with cognitive impairments in type 2 diabetic patients. Diabetes 63, 3596-3605.
16. Mehrabian S, Raycheva M, Gateva A, Todorova G, Angelova P, TraykovaM, Stankova T, Kamenov Z, Traykov L (2012) Cognitive dysfunction profile and arterial stiffness in type 2 diabetes. J Neurol Sci 322, 152-156.
17. Chen Y, Liu Z, Zhang J, Xu K, Zhang S, Wei D, Zhang Z (2014) Altered brain activation patterns under different working memory loads in patients with type 2 diabetes. Diabetes Care 37, 3157-3163.
18. SzémÁn B, Nagy G, Varga T, Veres-Székely A, Sasvári M, Fitala D, Szollosi A, Katonai R, Kotyuk E, Somogyi A (2012) Changes in cognitive function in patients with diabetes mellitus. Orv Hetil 153, 323-329.
19. Moran C, Phan TG, Chen J, Blizzard L, Beare R, Venn A, Münch G,Wood AG, Forbes J, Greenaway TM, Pearson S, SrikanthV(2013) Brain atrophy in type 2 diabetes: Regional distribution and influence on cognition. Diabetes Care 36, 4036-4042.
20. Hugenschmidt CE, Hsu FC, Hayasaka S, Carr JJ, Freedman BI, Nyenhuis DL,Williamson JD, Bowden DW(2013) The influence of subclinical cardiovascular disease and related risk factors on cognition in type 2 diabetes mellitus: The DHS-Mind study. J Diabetes Complications 27, 422-428.
21. Zhou H, Lu W, Shi Y, Bai F, Chang J, Yuan Y, Teng G, Zhang Z (2010) Impairments in cognition and resting-state connectivity of the hippocampus in elderly subjects with type 2 diabetes. Neurosci Lett 473, 5-10.
22. Bruehl H,Wolf OT, Sweat V, Tirsi A, Richardson S, Convit A(2009) Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Brain Res 1280, 186-194.
23. Yau PL, Kluger A, Borod JC, Convit A (2014) Neural substrates of verbal memory impairments in adults with type 2 diabetes mellitus. J Clin Exp Neuropsychol 36, 74-87.
24. García-Casares N, Jorge RE, García-Arnés JA, Acion L, Berthier ML, Gonzalez-Alegre P, Nabrozidis A, Gutiérrez A, Ariza MJ, Rioja J, GonzÁlez-Santos P (2014) Cognitive dysfunctions in middle-aged type 2 diabetic patients and neuroimaging correlations: A cross-sectional study. J Alzheimers Dis 42, 1337-1346.
25. Bangen KJ, Gu Y, Gross AL, Schneider BC, Skinner JC, Benitez A, Sachs BC, Shih R, Sisco S, Schupf N, Mayeux R, Manly JJ, Luchsinger JA (2015) Relationship between type 2 diabetes mellitus and cognitive change in a multiethnic elderly cohort. J Am Geriatr Soc 63, 1075-1083.
26. Cooray G, Nilsson E, Wahlin A, Laukka EJ, Brismar K, Brismar T (2011) Effects of intensified metabolic control on CNS function in type 2 diabetes. Psychoneuroendocrinology 36, 77-86.
27. Arvanitakis Z,Wilson RS, Li Y, Aggarwal NT, Bennett DA (2006) Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care 29, 560-565.
28. Beeri MS, Ravona-Springer R, Moshier E, Schmeidler J, Godbold J, Karpati T, Leroith D, Koifman K, Kravitz E, Price R, Hoffman H, Silverman JM, Heymann A (2014) The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics. Alzheimers Dement 10, 769-778.
29. Yogi-Morren D, Galioto R, Strandjord SE,Kennedy L, Manroa P, Kirwan JP, Kashyap S, Gunstad J (2014) Duration of type 2 diabetes and very low density lipoprotein levels are associated with cognitive dysfunction in metabolic syndrome. Cardiovasc Psychiatry Neurol 2014, 656341.
30. U'Ren RC, Riddle MC, Lezak MD, Bennington-Davis M (1990) The mental efficiency of the elderly person with type II diabetes mellitus. J Am Geriatr Soc 38, 505-510.
31. Cherbuin N, Sachdev P, Anstey KJ (2012) Higher normal fasting plasma glucose is associated with hippocampal atrophy: The PATH Study. Neurology 79, 1019-1026.
32. Morris JK, Vidoni ED, Honea RA, Burns JM (2014) Impaired glycemia increases disease progression in mild cognitive impairment. Neurobiol Aging 35, 585-589.
33. Kalousová M, Skrha J, Zima T (2002) Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51, 597-604.
34. Krapfenbauer K, Birnbacher R, Vierhapper H, Herkner K, Kampel D, Lubec G (1998) Glycoxidation, and protein and DNA oxidation in patients with diabetes mellitus. Clin Sci (Lond) 95, 331-337.
35. Nowotny K, Jung T, Höhn A, Weber D, Grune T (2015) Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 5, 194-222.
36. Gorska-Ciebiada M, Saryusz-Wolska M, Borkowska A, Ciebiada M, Loba J (2015) C-reactive protein, advanced glycation end products, and their receptor in type 2 diabetic, elderly patients with mild cognitive impairment. Front Aging Neurosci 7, 209.
37. Thome J, Münch G, Müller R, Schinzel R, Kornhuber J, Blum-Degen D, Sitzmann L, Rösler M, Heidland A, Riederer P (1996) Advanced glycation endproductsassociated parameters in the peripheral blood of patients with Alzheimer's disease. Life Sci 59, 679-685.
38. Sasaki N, Fukatsu R, Tsuzuki K, HayashiY,Yoshida T, Fujii N, Koike T,Wakayama I, Yanagihara R, Garruto R, Amano N, Makita Z (1998) Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol 153, 1149-1155.
39. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM (1999) Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53, 1937-1942.
40. Ravona-Springer R, Heymann A, Schmeidler J, Moshier E, Godbold J, SanoM,Leroith D, Johnson S, Preiss R,Koifman K, Hoffman H, Silverman JM, BeeriMS(2014) Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes. PLoS One 9, e97384.
41. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV (2009) Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301, 1565-1572.
42. Feinkohl I, Aung PP, Keller M, Robertson CM,Morling JR, McLachlan S, Deary IJ, Frier BM, Strachan MW, Price JF (2014) Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: The Edinburgh type 2 diabetes study. Diabetes Care 37, 507-515.
43. Bruce DG, Harrington N, Davis WA, Davis TM (2001) Dementia and its associations in type 2 diabetes mellitus: The Fremantle Diabetes Study. Diabetes Res Clin Pract 53, 165-172.
44. Petrova M, Prokopenko S, Pronina E, Mozheyko E (2010) Diabetes type 2, hypertension and cognitive dysfunction in middle age women. J Neurol Sci 299, 39-41.
45. Imamine R, KawamuraT, UmemuraT,Umegaki H, Kawano N, Hotta M, Kouchi Y, Hatsuda S, Watarai A, Kanai A, Nakashima E, Sano T, Sakakibara T, Nakamura J, Hotta N (2011) Does cerebral small vessel disease predict future decline of cognitive function in elderly people with type 2 diabetes? Diabetes Res Clin Pract 94, 91-99.
46. Brundel M, van den Heuvel M, de Bresser J, Kappelle LJ, Biessels GJ (2010) Cerebral cortical thickness in patients with type 2 diabetes. J Neurol Sci 299, 126-130.
47. Reijmer YD, van den Berg E, de Bresser J,Kessels RP, Kappelle LJ, Algra A, Biessels GJ (2011) Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors. Diabetes Metab Res Rev 27, 195-202.
48. Hassing LB, Johansson B, Nilsson SE, Berg S, Pedersen NL, Gatz M, McClearnG(2002) Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: A population-based study of the oldest old. Int Psychogeriatr 14, 239-248.
49. Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51, 1256-1262.
50. Murthy SB, Jawaid A, Qureshi SU, Kalkonde Y, Wilson AM, Johnson ML, Kunik ME, Schulz PE (2010) Does diabetes mellitus alter the onset and clinical course of vascular dementia? Behav Neurol 23, 145-151.
51. Exalto LG, Biessels GJ, Karter AJ, Huang ES, Quesenberry CP Jr, Whitmer RA (2014) Severe diabetic retinal disease and dementia risk in type 2 diabetes. J Alzheimers Dis 42(Suppl 3), S109-S117.
52. Crosby-Nwaobi RR, Sivaprasad S, Amiel S, Forbes A (2013) The relationship between diabetic retinopathy and cognitive impairment. Diabetes Care 36, 3177-3186.
53. Brundel M, Reijmer YD, van Veluw SJ, Kuijf HJ, Luijten PR, Kappelle LJ, Biessels GJ (2014) Cerebral microvascular lesions on high-resolution 7-Tesla MRI in patients with type 2 diabetes. Diabetes 63, 3523-3529.
54. Kamiyama K, Wada A, Sugihara M, Kurioka S, Hayashi K, Hayashi T, Yoshisako T, Yamamoto N, Tsuchie Y, Yamaguchi S, Sugimoto T, Kitagaki H (2010) Potential hippocampal region atrophy in diabetes mellitus type 2: A voxel-based morphometry VSRAD study. Jpn J Radiol 28, 266-272.
55. Hayashi K, Kurioka S, Yamaguchi T, Morita M, Kanazawa I, Takase H, Wada A, Kitagaki H, Nagai A, Bokura H, Yamaguchi S, Sugimoto T (2011) Association of cognitive dysfunction with hippocampal atrophy in elderly Japanese people with type 2 diabetes. Diabetes Res Clin Pract 94, 180-185.
56. de Bresser J, Tiehuis AM, van den Berg E, Reijmer YD, Jongen C, Kappelle LJ, Mali WP, Viergever MA, Biessels GJ (2010) Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes. Diabetes Care 33, 1309-1314.
57. Wang C, Fu K, Liu H, Xing F, Zhang S (2014) Brain structural changes and their correlation with vascular disease in type 2 diabetes mellitus patients: A voxel-based morphometric study. Neural Regen Res 9, 1548-1556.
58. Jongen C, van der Grond J, Kappelle LJ, Biessels GJ, Viergever MA, Pluim JP (2007) Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia 50, 1509-1516.
59. Biessels GJ, De Leeuw FE, Lindeboom J, Barkhof F, Scheltens P (2006) Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus. J Neurol Neurosurg Psychiatry 77, 304-307.
60. den Heijer T,Vermeer SE, van Dijk EJ, Prins ND,Koudstaal PJ, Hofman A, Breteler MM (2003) Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46, 1604-1610.
61. Gold SM, Dziobek I, Sweat V, Tirsi A, Rogers K, Bruehl H, Tsui W, Richardson S, Javier fE, Convit A (2007) Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 50, 711-719.
62. Wisse LE, de Bresser J, Geerlings MI, Reijmer YD, Portegies ML, Brundel M, Kappelle LJ, van der Graaf Y, Biessels GJ (2014) Global brain atrophy but not hippocampal atrophy is related to type 2 diabetes. J Neurol Sci 344, 32-36.
63. Moran C, Beare R, Phan TG, Bruce DG, Callisaya ML, Srikanth V (2015) Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology 85, 1123-1130.
64. Zhang Y, Zhang X, Zhang J, Liu C, Yuan Q, Yin X, Wei L, Cui J, Tao R, Wei P, Wang J (2014) Gray matter volume abnormalities in type 2 diabetes mellitus with and without mild cognitive impairment. Neurosci Lett 562, 1-6.
65. Roberts RO, Knopman DS, Przybelski SA, Mielke MM, Kantarci K, Preboske GM, Senjem ML, Pankratz VS, Geda YE, Boeve BF, Ivnik RJ, RoccaWA, Petersen RC, Jack CR Jr (2014) Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology 82, 1132-1141.
66. Kryscio RJ, Abner EL, Lin Y, Cooper GE, Fardo DW, Jicha GA, Nelson PT, Smith CD,Van Eldik LJ,WanL, Schmitt FA (2013) Adjusting for mortality when identifying risk factors for transitions to mild cognitive impairment and dementia. J Alzheimers Dis 35, 823-832.
67. Gao Y, Xiao Y, Miao R, Zhao J, Cui M, Huang G, Fei M (2016) The prevalence of mild cognitive impairment with type 2 diabetes mellitus among elderly people in China: A cross-sectional study. Arch Gerontol Geriatr 62, 138-142.
68. Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R (2007) Relation of diabetes to mild cognitive impairment. Arch Neurol 64, 570-575.
69. Lee YJ, Kang HM, Kim NK, Yang JY, Noh JH, Ko KS, Rhee BD, Kim DJ (2014) Factors associated for mild cognitive impairment in older korean adults with type 2 diabetes mellitus. Diabetes Metab J 38, 150-157.
70. Solfrizzi V, Panza F, Colacicco AM, D'Introno A, Capurso C, Torres F, Grigoletto F, Maggi S, Del Parigi A, Reiman EM, Caselli RJ, Scafato E, Farchi G, Capurso A (2004) Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 63, 1882-1891.
71. Niu MJ, Yin FZ, Liu LX, Fang Y, Xuan XM,Wu GF (2013) Non-high-density lipoprotein cholesterol and other risk factors of mild cognitive impairment among Chinese type 2 diabetic patients. J Diabetes Complications 27, 443-446.
72. Winkler A, Dlugaj M, Weimar C, Jöckel KH, Erbel R, Dragano N, Moebus S (2014) Association of diabetes mellitus and mild cognitive impairment in middle-aged men and women. J Alzheimers Dis 42, 1269-1277.
73. Chen RH, Jiang XZ, Zhao XH, Qin YL, Gu Z, Gu PL, Zhou B, Zhu ZH, Xu LY, Zou YF (2012) Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: A cross-section study. Ann Endocrinol (Paris) 73, 208-212.
74. Ma F, Wu T, Miao R, Xiao YY, Zhang W, Huang G (2015) Conversion of mild cognitive impairment to dementia among subjects with diabetes: A population-based study of incidence and risk factors with five years of follow-up. J Alzheimers Dis 43, 1441-1449.
75. RobertsRO, Knopman DS, Geda YE, Cha RH, Pankratz VS, Baertlein L, Boeve BF, Tangalos EG, Ivnik RJ, MielkeMM, Petersen RC (2014) Association of diabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimers Dement 10, 18-26.
76. Rizzo MR, Barbieri M, Boccardi V, Angellotti E, Marfella R, Paolisso G (2014) Dipeptidyl peptidase-4 inhibitors have protective effect on cognitive impairment in aged diabetic patients with mild cognitive impairment. J Gerontol A Biol Sci Med Sci 69, 1122-1131.
77. Chen RH, Zhao XH, Gu Z, Gu PL, Zhou B, Zhu ZH, Xu LY, Zou YF, Jiang XZ (2014) Serum levels of 25-hydroxyvitaminDare associated with cognitive impairment in type 2 diabetic adults. Endocrine 45, 319-324.
78. Chen G, Cai L, Chen B, Liang J, Lin F, Li L, Lin L, Yao J, Wen J, Huang H (2011) Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment. Diabetes Care 34, 2586-2590.
79. Gao Y, Xiao Y, Miao R, Zhao J, Zhang W, Huang G, Ma F (2015) The characteristic of cognitive function in Type 2 diabetes mellitus. Diabetes Res Clin Pract 109, 299-305.
80. Toro P, Schönknecht P, Schröder J (2009) Type II diabetes in mild cognitive impairment and Alzheimer's disease: Results from a prospective population-based study in Germany. J Alzheimers Dis 16, 687-691.
81. ZhouY, Fang R, Liu LH, Chen SD, TangHD(2015) Clinical characteristics for the relationship between type-2 diabetes mellitus and cognitive impairment: A cross-sectional study. Aging Dis 6, 236-244.
82. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, Palumbo PJ (1997) Risk of dementia among persons with diabetes mellitus: A population-based cohort study. Am J Epidemiol 145, 301-308.
83. Cheng D, Noble J, Tang MX, Schupf N, Mayeux R, Luchsinger JA (2011) Type 2 diabetes and late-onset Alzheimer's disease. Dement Geriatr Cogn Disord 31, 424-430.
84. Malek-Ahmadi M, Beach T, Obradov A, Sue L, Belden C, Davis K,Walker DG, Lue L, Adem A, Sabbagh MN (2013) Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE -.4 carrier status. Curr Alzheimer Res 10, 654-659.
85. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC (2004) Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53, 474-481.
86. Roberts RO, Knopman DS, Cha RH, MielkeMM, Pankratz VS, Boeve BF, Kantarci K, Geda YE, Jack CR Jr, Petersen RC, Lowe VJ (2014) Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation. J Nucl Med 55, 759-764.
87. Heitner J, DicksonD(1997) Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 49, 1306-1311.
88. Tariot PN, Ogden MA, Cox C,Williams TF (1999) Diabetes and dementia in long-term care. J Am Geriatr Soc 47, 423-429.
89. Beeri MS, Silverman JM, Davis KL, Marin D, Grossman HZ, Schmeidler J, Purohit DP, Perl DP, Davidson M, Mohs RC, Haroutunian V (2005) Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci 60, 471-475.
90. Domínguez RO, Marschoff ER, GonzÁlez SE, Repetto MG, Serra JA (2012) Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients. Diabetes Res Clin Pract 98, 68-74.
91. Plastino M, Fava A, Pirritano D, Cotronei P, Sacco N, Sperlí T, Spanò A, Gallo D, Mungari P, Consoli D, Bosco D (2010) Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. J Neurol Sci 288, 112-116.
92. Chen JM, Chang CW, Chang TH, Hsu CC, Horng JT, Sheu WH (2014) Effects of statins on incident dementia in patients with type 2 DM: A population-based retrospective cohort study in Taiwan. PLoS One 9, e88434.
93. Rönnemaa E, Zethelius B, Sundelöf J, Sundström J, Degerman-Gunnarsson M, Berne C, Lannfelt L, Kilander L (2008) Impaired insulin secretion increases the risk of Alzheimer disease. Neurology 71, 1065-1071.
94. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, Craft S (2011) Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 68, 51-57.
95. Craft S (2007) Insulin resistance and Alzheimer's disease pathogenesis: Potential mechanisms and implications for treatment. Curr Alzheimer Res 4, 147-152.
96. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2011) Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J Pathol 225, 54-62.
97. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2009) Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease. J Neurochem 111, 242-249.
98. Kim I, Lee J, Hong HJ, Jung ES,Ku YH, Jeong IK, Cho YM, So I, Park KS, Mook-Jung I (2010) A relationship between Alzheimer's disease and type 2 diabetes mellitus through the measurement of serum amyloid-beta autoantibodies. J Alzheimers Dis 19, 1371-1376.